Insmed (INSM) Total Debt Growth (3y) (2015 - 2026)
Insmed (INSM) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Insmed |
19.79 Bn |
18.57 Bn |
258.54 Mn |
-21.76% |
| Date | Value |
|---|
| Mar 31, 2026 |
-21.76% |
| Dec 31, 2025 |
-21.66% |
| Sep 30, 2025 |
-11.73% |
| Jun 30, 2025 |
-11.77% |
| Mar 31, 2025 |
12.16% |
| Dec 31, 2024 |
24.88% |
| Sep 30, 2024 |
19.64% |
| Jun 30, 2024 |
28.75% |
| Mar 31, 2024 |
47.63% |
| Dec 31, 2023 |
48.01% |
| Sep 30, 2023 |
48.40% |
| Jun 30, 2023 |
48.79% |
| Mar 31, 2023 |
49.19% |
| Dec 31, 2022 |
49.62% |
| Sep 30, 2022 |
33.34% |
| Jun 30, 2022 |
33.96% |
| Mar 31, 2022 |
34.58% |
| Dec 31, 2021 |
21.41% |
| Sep 30, 2021 |
21.37% |
| Jun 30, 2021 |
21.34% |
